ALVOGEN, INC.

Lobbying client · New Jersey · filed 2025 to 2026

Pharmaceutical company.

$120,000 Reported spend

5 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page is grouped by the client's LDA id (69458), not by name.

Firms hired 1

FOLEY & LARDNER LLP $120,000 5 filings

Reported by year 2 years

2026 $60,000 2 filings
2025 $60,000 3 filings

Issues lobbied 2

Health Issues 5
Government Issues 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

HOUSE OF REPRESENTATIVES 4
SENATE 4
White House Office 3
Centers For Medicare and Medicaid Services (CMS) 1

Recent filings 5 total

Q2

FOLEY & LARDNER LLP

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $30,000 income · posted Jul 19, 2026

View → Q1

FOLEY & LARDNER LLP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $30,000 income · posted Apr 20, 2026

View → Q4

FOLEY & LARDNER LLP

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $30,000 income · posted Jan 19, 2026

View → Q3

FOLEY & LARDNER LLP

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $30,000 income · posted Oct 21, 2025

View → RR

FOLEY & LARDNER LLP

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 20, 2025

View →

Foreign entities disclosed 1

ALVOGEN LUX HOLDINGS SARL Luxembourg named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.